LncRNA H19 overexpression induces bortezomib resistance in multiple myeloma by targeting MCL-1 via miR-29b-3p

Radiotherapy, chemotherapy, autologous/allogeneic stem cell transplantation, and targeted drug therapy are currently available therapeutic options for multiple myeloma (MM), but the clinical outcome remains unsatisfactory owing to frequent occurrence of drug resistance. Anti apoptosis is one of the...

Descripción completa

Detalles Bibliográficos
Autores principales: Pan, Yafang, Zhang, Yu, Liu, Wenwen, Huang, Yan, Shen, Xianjuan, Jing, Rongrong, Pu, Jiang, Wang, Xudong, Ju, Shaoqing, Cong, Hui, Chen, Hongmei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6365572/
https://www.ncbi.nlm.nih.gov/pubmed/30728351
http://dx.doi.org/10.1038/s41419-018-1219-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6365572/
https://www.ncbi.nlm.nih.gov/pubmed/30728351
http://dx.doi.org/10.1038/s41419-018-1219-0

Ejemplares similares